Deferasirox for managing iron overload in people with myelodysplastic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Deferasirox for Managing Iron Overload in People With Myelodysplastic Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome.
Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome. Accessed February 12, 2025.
Deferasirox for managing iron overload in people with myelodysplastic syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome
Deferasirox for Managing Iron Overload in People With Myelodysplastic Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Deferasirox for managing iron overload in people with myelodysplastic syndrome
ID - 434021
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -